Mohammed Elsherif1, Ahmed Esmael2. 1. Department of Neurology, Mansoura Faculty of Medicine, Mansoura University, Mansoura, 35516, Dakahlia, Egypt. elsherifmohammed@mans.edu.eg. 2. Department of Neurology, Mansoura Faculty of Medicine, Mansoura University, Mansoura, 35516, Dakahlia, Egypt.
Abstract
OBJECTIVE: Cognitive impairment in temporal lobe epilepsy is widely acknowledged as one of the most well-known comorbidities. This study aimed to explore cognitive impairment and to determine the potential clinical, radiological, and quantitative electroencephalography markers for cognitive impairment in temporal lobe epilepsy patients versus extra-temporal lobe epilepsy. METHODS: Forty-five patients with temporal lobe epilepsy and forty-five patients with extra-temporal lobe epilepsy were recruited for an administered digit span test, verbal fluency test, mini-mental state examination, digital symbol test, and Montreal cognitive assessment. Also, they were subjected to magnetic resonance imaging assessment for hippocampal atrophy and a quantitative electroencephalography assessment for electroencephalography markers (median frequency, peak frequency, and the alpha-to-theta ratio). RESULTS: Patients with extra-temporal lobe epilepsy showed non-significant higher epilepsy durations and a higher frequency of seizures. Temporal lobe epilepsy patients showed a more statistically significant family history of epilepsy (37.7%), more history of febrile convulsions (13.3%), higher hippocampal atrophy (17.8%), and lower cognitive scales, especially mini-mental state examination and Montreal cognitive assessment; lower digital symbol test, verbal fluency test, and backward memory of digit span test. Also, temporal lobe epilepsy patients had a strong negative correlation with electroencephalography markers: median frequency, peak frequency, and the alpha-to-theta ratio (r = - 0.68, P < 0.005 and r = - 0.64, P < 0.005 and r = - 0.66, P < 0.005 respectively). CONCLUSION: Cognitive impairment in patients with temporal lobe epilepsy was correlated with hippocampal atrophy and quantitative electroencephalography abnormalities, especially peak frequency, median frequency, and alpha-to-theta ratio that could be used alone for the identification of early cognitive impairment. TRIAL REGISTRATION: Clinicaltrials.gov: NCT04376671.
OBJECTIVE: Cognitive impairment in temporal lobe epilepsy is widely acknowledged as one of the most well-known comorbidities. This study aimed to explore cognitive impairment and to determine the potential clinical, radiological, and quantitative electroencephalography markers for cognitive impairment in temporal lobe epilepsy patients versus extra-temporal lobe epilepsy. METHODS: Forty-five patients with temporal lobe epilepsy and forty-five patients with extra-temporal lobe epilepsy were recruited for an administered digit span test, verbal fluency test, mini-mental state examination, digital symbol test, and Montreal cognitive assessment. Also, they were subjected to magnetic resonance imaging assessment for hippocampal atrophy and a quantitative electroencephalography assessment for electroencephalography markers (median frequency, peak frequency, and the alpha-to-theta ratio). RESULTS: Patients with extra-temporal lobe epilepsy showed non-significant higher epilepsy durations and a higher frequency of seizures. Temporal lobe epilepsy patients showed a more statistically significant family history of epilepsy (37.7%), more history of febrile convulsions (13.3%), higher hippocampal atrophy (17.8%), and lower cognitive scales, especially mini-mental state examination and Montreal cognitive assessment; lower digital symbol test, verbal fluency test, and backward memory of digit span test. Also, temporal lobe epilepsy patients had a strong negative correlation with electroencephalography markers: median frequency, peak frequency, and the alpha-to-theta ratio (r = - 0.68, P < 0.005 and r = - 0.64, P < 0.005 and r = - 0.66, P < 0.005 respectively). CONCLUSION: Cognitive impairment in patients with temporal lobe epilepsy was correlated with hippocampal atrophy and quantitative electroencephalography abnormalities, especially peak frequency, median frequency, and alpha-to-theta ratio that could be used alone for the identification of early cognitive impairment. TRIAL REGISTRATION: Clinicaltrials.gov: NCT04376671.
Authors: Martin Vyhnalek; Tomas Nikolai; Ross Andel; Zuzana Nedelska; Eva Rubínová; Hana Marková; Jan Laczó; Ondrej Bezdicek; Katerina Sheardova; Jakub Hort Journal: J Alzheimers Dis Date: 2014 Impact factor: 4.472
Authors: Colleen K DiIorio; Yvan A Bamps; Ariele L Edwards; Cam Escoffery; Nancy J Thompson; Charles E Begley; Ross Shegog; Noreen M Clark; Linda Selwa; Shelley C Stoll; Robert T Fraser; Paul Ciechanowski; Erica K Johnson; Rosemarie Kobau; Patricia H Price Journal: Epilepsy Behav Date: 2010-11 Impact factor: 2.937
Authors: Hamdy N A El Tallawy; Wafaa M A Farghaly; Tarek A Rageh; Ghaydaa A Shehata; Nabil A Metwaly; Noha Abo Elftoh; Ahmed M Hegazy; Esam A El Moselhy; Ibrahim Rayan; Bastawy M A Al Fawal; Mohamed A Abd Elhamed Journal: Neuroepidemiology Date: 2010-10-14 Impact factor: 3.282
Authors: Naira Goukasian; Shai Porat; Anna Blanken; David Avila; Dimitar Zlatev; Sona Hurtz; Kristy S Hwang; Jonathan Pierce; Shantanu H Joshi; Ellen Woo; Liana G Apostolova Journal: Dement Geriatr Cogn Dis Extra Date: 2019-08-13